Viewing Study NCT04822805


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-01-01 @ 12:55 AM
Study NCT ID: NCT04822805
Status: UNKNOWN
Last Update Posted: 2021-03-30
First Post: 2021-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
Sponsor: First People's Hospital of Hangzhou
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module